Aripiprazole Open-Label, Safety and Tolerability Study

NCT00102518 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

325

Enrollment

INDUSTRY

Sponsor class

Conditions

Schizophrenia
Bipolar Disorder

Interventions

DRUG: Aripiprazole

Sponsor

Otsuka Pharmaceutical Development & Commercialization, Inc.